Envoy Medical, Inc.
COCH
$1.12
-$0.03-2.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.85% | -8.23% | 22.52% | -51.00% | 37.05% |
| Total Depreciation and Amortization | 39.34% | 27.08% | -2.04% | 16.67% | 23.53% |
| Total Amortization of Deferred Charges | -0.40% | -76.41% | -- | -- | -0.37% |
| Total Other Non-Cash Items | 1,811.63% | -70.34% | -92.55% | 257.19% | -178.40% |
| Change in Net Operating Assets | -91.65% | 191.29% | -187.22% | 407.89% | 118.97% |
| Cash from Operations | -19.73% | 15.11% | -56.32% | 39.58% | 16.87% |
| Capital Expenditure | 83.33% | -101.12% | 146.15% | -46.46% | -624.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 83.33% | -101.12% | 186.83% | 22.15% | -624.77% |
| Total Debt Issued | 0.00% | 0.00% | -33.33% | 200.00% | -50.00% |
| Total Debt Repaid | -1.29% | 74.56% | -- | -- | -1.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 49.96% | -97.56% | 66.50% | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24.87% | -27.68% | -19.46% | 172.61% | -65.17% |
| Foreign Exchange rate Adjustments | -133.33% | 400.00% | -100.00% | 0.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.38% | -116.15% | -60.46% | 183.71% | -540.03% |